Fig. 1
From: Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients
Immunohistochemical (IHC) staining of HER2 and HER3 expression in gastric cancer. HER2 negative staining (a), HER2 weak staining (b), HER2 moderate staining (c) and HER2 strong staining (d). HER3 negative staining (e), HER3 weak staining (f), HER3 moderate staining (g) and HER3 strong staining (h).Original magnification, ×200
